Steve Rhodes Interviewed in The Motley Fool

3 Things We Learned from an Interview with Trendlines Group Ltd’s Management

By Stanley Lim Peir Shenq, CFA (29 November 2016)

Trendlines Investment team Todd Dollinger, Judith Kleinman, Gabi Heller, Steve Rhodes

Trendlines Investment team (l to r): Todd Dollinger (Chairman & CEO), Judith Kleinman (Director Investor Relations & Corporate Communications), Gabi Heller (CFO), Steve Rhodes (Chairman & CEO)

Earlier this month, The Motley Fool Singapore was invited to meet with Trendlines Group Ltd.’s (SGX:42T) Chairman and Chief Executive Officer, Stephen “Steve” Rhodes.

Trendlines is a relatively new listed company in Singapore’s stock market, having floated its shares only in November 2015. The company is a venture capital investor based in Israel and it invests mainly in companies that deal with medical devices and agriculture technologies.

Here are three interesting things we learned from our exclusive interview with Steve Rhodes.

Shark Tank; Trendlines Style

When Steve Rhodes was describing his company’s business model during the meeting, I could not help but think of the similarity between Trendlines and the reality TV programme Shark Tank.

For those of you who are unfamiliar with Shark Tank, it is a show featuring entrepreneurs who would pitch their companies or ideas to a panel of investors, in the hopes of obtaining an investment from the panel.

In a similar manner, Trendlines also has many entrepreneurs coming to them all the time to ask for capital. In fact, according to Steve, Trendlines evaluates about 500 proposals a year. The company has two permanent staff in Israel sourcing investment opportunities.

But, unlike Shark Tank, Trendlines goes through a thorough evaluation process before investing in any startup. It might take up to nine months of evaluation before the company makes an investment. The company is also very strict when it comes to selecting the startups that it wants to invest in. Within any given year, Trendlines might only invest in eight new startups out of the 500 or so proposals it receives.

See the other two things The Motley Fool learned from its interview with Steve in the full article.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+